Quality Management Optimizing HEDIS & STARSCommercialJanuary 16, 2025

Asthma Medication Ratio (AMR) 2025

HEDIS® is a widely used set of performance measures developed and maintained by the National Committee for Quality Assurance (NCQA). These are used to drive improvement efforts surrounding best practices.

HEDIS measure

This HEDIS measure looks at the percentage of patients 5 to 64 years old who were identified as having persistent asthma and had a ratio of controller medications to total asthma medications

Refer to attachments to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Commercial services provided by Anthem Blue Cross and Blue Shield, trade name of Anthem HealthChoice HMO, Inc. and Anthem HealthChoice Assurance, Inc., or Anthem Blue Cross and Blue Shield HP, trade name of Anthem HP, LLC.
Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BC-CM-075667-24-CPN74724, MULTI-BCBS-CM-075668-24-CPN74724

ATTACHMENTS: Asthma Medication Ratio (AMR) 2025 - Blue Cross (pdf - 0.34mb), Asthma Medication Ratio (AMR) 2025 - Blue Cross Blue Shield (pdf - 0.34mb)